ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,612Medicare Part D Prescriptions Filled, Including Refills

Rank: 101 out of 1206

$554K Total Retail Price of All Prescriptions

Rank: 120 out of 1206

387 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
29% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 387 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 387 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

1% of this provider’s 10,926 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$44 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
LEVOTHYROXINE SODIUM 655 600 1 2
SIMVASTATIN 471 424 2 1
OMEPRAZOLE 431 379 3 3
AMLODIPINE BESYLATE 398 371 4 6
WARFARIN SODIUM 398 385 4 8
FUROSEMIDE 382 347 6 5
LOSARTAN POTASSIUM 343 328 7 20
METFORMIN HCL 322 283 8 10
ALLOPURINOL 275 264 9 24
POTASSIUM CHLORIDE 242 200 10 12
PRAVASTATIN SODIUM 239 212 11 21
METOPROLOL TARTRATE 223 200 12 9
HYDROCHLOROTHIAZIDE 219 195 13 11
HYDROCODONE-ACETAMINOPHEN 205 128 S3 14 7
METOPROLOL SUCCINATE 200 172 15 15
FENOFIBRATE 186 171 16 56
SERTRALINE HCL 185 185 17 22
TRAMADOL HCL 185 140 17 17
CITALOPRAM HBR 173 151 19 16
LISINOPRIL 134 122 20 4
CARBIDOPA-LEVODOPA 134 114 20 70
DIGOXIN 129 129 22 43
BUMETANIDE 129 113 22 101
MELOXICAM 126 111 24 35
ATORVASTATIN CALCIUM 123 112 25 13
GABAPENTIN 122 89 26 18
ALENDRONATE SODIUM 115 99 27 19
TAMSULOSIN HCL 111 97 28 26
METHOCARBAMOL 110 49 R 29 185
DICLOFENAC SODIUM 105 97 30 104
NAMENDA 99 99 31 36
ZOLPIDEM TARTRATE 94 77 32 25
CARVEDILOL 91 86 33 32
BUSPIRONE HCL 90 83 34 110
BENAZEPRIL HCL 88 82 35 39
ATENOLOL 86 79 36 14
ENALAPRIL MALEATE 80 74 37 45
RISPERIDONE 78 48 38 74
CRESTOR 77 77 39 30
CELEBREX 74 63 40 84
ZETIA 73 68 41 73
POLYETHYLENE GLYCOL 3350 73 63 41 31
TORSEMIDE 71 70 43 144
AGGRENOX 68 63 44 176
ISOSORBIDE MONONITRATE ER 67 64 45 40
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 46 60
GLIPIZIDE 62 51 47 64
DIOVAN 61 59 48 57
DICYCLOMINE HCL 56 56 49 279
DONEPEZIL HCL 56 56 49 29
CARBAMAZEPINE 55 30 51 146
RANITIDINE HCL 54 42 52 23
NEXIUM 53 47 53 47
AZITHROMYCIN 53 46 53 46
AMLODIPINE BESYLATE-BENAZEPRIL 52 52 55 76
OXYBUTYNIN CHLORIDE 51 46 56 68
LANTUS 51 51 56 38
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 31, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.